These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


174 related items for PubMed ID: 30705364

  • 1. Memory-like Liver Natural Killer Cells are Responsible for Islet Destruction in Secondary Islet Transplantation.
    Saeki Y, Ishiyama K, Ishida N, Tanaka Y, Ohdan H.
    Sci Rep; 2019 Jan 31; 9(1):1022. PubMed ID: 30705364
    [Abstract] [Full Text] [Related]

  • 2. Role of Natural Killer Cells in the Innate Immune System After Intraportal Islet Transplantation in Mice.
    Saeki Y, Ishiyama K, Ishida N, Tanaka Y, Ohdan H.
    Transplant Proc; 2017 Jan 31; 49(1):139-144. PubMed ID: 28104122
    [Abstract] [Full Text] [Related]

  • 3. Liver natural killer cells play a role in the destruction of islets after intraportal transplantation.
    Ishiyama K, Rawson J, Omori K, Mullen Y.
    Transplantation; 2011 May 15; 91(9):952-60. PubMed ID: 21389902
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of islet engraftment and achievement of long-term islet allograft survival by Toll-like receptor 4 blockade.
    Giovannoni L, Muller YD, Lacotte S, Parnaud G, Borot S, Meier RP, Lavallard V, Bédat B, Toso C, Daubeuf B, Elson G, Shang L, Morel P, Kosco-Vilbois M, Bosco D, Berney T.
    Transplantation; 2015 Jan 15; 99(1):29-35. PubMed ID: 25340601
    [Abstract] [Full Text] [Related]

  • 5. Antibody-induced NKG2D blockade in a rat model of intraportal islet transplantation leads to a deleterious reaction.
    Delaune V, Toso C, Kahler-Quesada A, Slits F, Gex Q, Kaya G, Lavallard V, Orci LA, Peloso A, Lacotte S.
    Transpl Int; 2020 Jun 15; 33(6):675-688. PubMed ID: 32003082
    [Abstract] [Full Text] [Related]

  • 6. Clinical-scale isolation of interleukin-2-stimulated liver natural killer cells for treatment of liver transplantation with hepatocellular carcinoma.
    Ohira M, Nishida S, Tryphonopoulos P, Tekin A, Selvaggi G, Moon J, Levi D, Ricordi C, Ishiyama K, Tanaka Y, Ohdan H, Tzakis AG.
    Cell Transplant; 2012 Jun 15; 21(7):1397-406. PubMed ID: 22469170
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. HMGB1-Mediated Early Loss of Transplanted Islets Is Prevented by Anti-IL-6R Antibody in Mice.
    Itoh T, Nitta T, Nishinakamura H, Kojima D, Mera T, Ono J, Kodama S, Yasunami Y.
    Pancreas; 2015 Jan 15; 44(1):166-71. PubMed ID: 25058889
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Valpha14 NK T cell-triggered IFN-gamma production by Gr-1+CD11b+ cells mediates early graft loss of syngeneic transplanted islets.
    Yasunami Y, Kojo S, Kitamura H, Toyofuku A, Satoh M, Nakano M, Nabeyama K, Nakamura Y, Matsuoka N, Ikeda S, Tanaka M, Ono J, Nagata N, Ohara O, Taniguchi M.
    J Exp Med; 2005 Oct 03; 202(7):913-8. PubMed ID: 16186183
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of instant blood-mediated inflammatory responses by co-immobilization of sCR1 and heparin on islets.
    Luan NM, Iwata H.
    Biomaterials; 2013 Jul 03; 34(21):5019-24. PubMed ID: 23578554
    [Abstract] [Full Text] [Related]

  • 13. Hepatectomy leads to loss of TRAIL-expressing liver NK cells via downregulation of the CXCL9-CXCR3 axis in mice.
    Yano T, Ohira M, Nakano R, Tanaka Y, Ohdan H.
    PLoS One; 2017 Jul 03; 12(10):e0186997. PubMed ID: 29088306
    [Abstract] [Full Text] [Related]

  • 14. Heterogeneity and neurovascular integration of intraportally transplanted islets revealed by 3-D mouse liver histology.
    Chen CC, Peng SJ, Wu PY, Chien HJ, Lee CY, Chung MH, Tang SC.
    Am J Physiol Endocrinol Metab; 2021 Jun 01; 320(6):E1007-E1019. PubMed ID: 33900850
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
    Wei H, Zheng X, Lou D, Zhang L, Zhang R, Sun R, Tian Z.
    Mol Immunol; 2005 May 01; 42(9):1023-31. PubMed ID: 15829292
    [Abstract] [Full Text] [Related]

  • 17. Engraftment Site and Effectiveness of the Pan-Caspase Inhibitor F573 to Improve Engraftment in Mouse and Human Islet Transplantation in Mice.
    Pepper AR, Bruni A, Pawlick R, Wink J, Rafiei Y, Gala-Lopez B, Bral M, Abualhassan N, Kin T, Shapiro AMJ.
    Transplantation; 2017 Oct 01; 101(10):2321-2329. PubMed ID: 28072753
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice.
    Matsuoka N, Itoh T, Watarai H, Sekine-Kondo E, Nagata N, Okamoto K, Mera T, Yamamoto H, Yamada S, Maruyama I, Taniguchi M, Yasunami Y.
    J Clin Invest; 2010 Mar 01; 120(3):735-43. PubMed ID: 20124731
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-1beta and inducible form of nitric oxide synthase expression in early syngeneic islet transplantation.
    Montolio M, Biarnés M, Téllez N, Escoriza J, Soler J, Montanya E.
    J Endocrinol; 2007 Jan 01; 192(1):169-77. PubMed ID: 17210754
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.